Cyclodextrin-based pharmaceutics: past, present and future

By Mark E. Davis, M. Brewster. Nature reviews. Drug discovery, 2004

1,884 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Design and development of polymers for gene delivery (2005, background): “More details on this class of linear polymer is available in recent review”
Pharmaceutical applications of cyclodextrins: basic science and product development (2010, background): “; Davis & Brewster([14]); Van Ommen et al.”
A green synthesis of copper nanoparticles using native cyclodextrins as stabilizing agents (2016, positive): “These cyclic oligosaccharides possess a non-toxic nature, so they have applications in the pharmaceutical, food, and cosmetic industry, as well as in analytical separations [31–35].”
Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. (2007, background): “Cyclodextrins (CDs) are cyclic oligosaccharides consisting of α-(1–4)-linked D-glycopyranose units, which are primary degradation products of starch (reviewed by Davis and Brewster (2004) [1] and Uekama (2004) [2]).”